TY - JOUR
T1 - Three-dimensional structure of the human protective protein
T2 - structure of the precursor form suggests a complex activation mechanism
AU - Rudenko, Gabby
AU - Bonten, Erik
AU - d'Azzo, Alessandra
AU - GJ Hol, Wim
N1 - Funding Information:
Dr H Galjaard (Clinical Genetics Foundation, Rotterdam) is most gratefully acknowledged for support in the initial stages of the project. Dr J Remington kindly provided the atomic coordinates of the wheat and the yeast serine carboxypeptidases prior to publication; Drs G Kleywegt and A Jones made the RAVE averaging software and documentation available prior to publication. Drs R Read and B Hazes are thanked for the encouragement and helpful advice during the early stages of the structure determination. The Stanford Synchrotron Radiation Laboratories provided excellent facilities. GR is greatly indebted to the lecturers of the FEBS/EACMB Workshop, Århus 1992, the ESF Molecular Replacement Workshop in Paris (1992) (especially Dr I Tickle), and the EMBO course in Heidelberg (1993). The discussions with Dr B Dijkstra and the Groningen crystallography group are kindly acknowledged, as well as Dr C Verlinde for creating the computer graphics cluster in Seattle. These studies were supported in part by the NIH Cancer Center Support CORE Grant P30-CA21765 and the American Lebanese Syrian Associated Charities (ALSAC). WGJH acknowledges receipt of a major equipment grant from the Murdock Charitable Trust.
PY - 1995/11
Y1 - 1995/11
N2 - Background: The human 'protective protein' (HPP) forms a multi-enzyme complex with β-galactosidase and neuraminidase in the lysosomes, protecting these two glycosidases from degradation. In humans, deficiency of HPP leads to the lysosomal storage disease galactosialidosis. Proteolytic cleavage of the precursor form of HPP involves removal of a 2 kDa excision peptide and results in a carboxypeptidase activity. The physiological relevance of this activity is, as yet, unknown. Results The crystal structure of the 108 kDa dimer of the precursor HPP has been elucidated by making extensive use of twofold density averaging. The monomer consists of a 'core' domain and a 'cap' domain. Comparison with the distantly related wheat serine carboxypeptidase dimer shows that the two subunits in the HPP dimer differ by 15° in mutual orientation. Also, the helical subdomain forming part of the cap domains is very different. In addition, the HPP precursor cap domain contains a 'maturation' subdomain of 49 residues which fills the active-site cleft. Merely removing the 'excision' peptide located in the maturation subdomain does not render the catalytic triad solvent accessible. Conclusion The activation mechanism of HPP is unique among proteases with known structure. It differs from the serine proteases in that the active site is preformed in the zymogen, but is blocked by a maturation subdomain. In contrast to the zinc metalloproteases and aspartic proteases, the chain segment physically rendering the catalytic triad solvent inaccessible in HPP is not cleaved off to form the active enzyme. The activation must be a multi-step process involving removal of the excision peptide and major conformational changes of the maturation subdomain, whereas the conformation of the enzymatic machinery is probably almost, or completely, unaffected.
AB - Background: The human 'protective protein' (HPP) forms a multi-enzyme complex with β-galactosidase and neuraminidase in the lysosomes, protecting these two glycosidases from degradation. In humans, deficiency of HPP leads to the lysosomal storage disease galactosialidosis. Proteolytic cleavage of the precursor form of HPP involves removal of a 2 kDa excision peptide and results in a carboxypeptidase activity. The physiological relevance of this activity is, as yet, unknown. Results The crystal structure of the 108 kDa dimer of the precursor HPP has been elucidated by making extensive use of twofold density averaging. The monomer consists of a 'core' domain and a 'cap' domain. Comparison with the distantly related wheat serine carboxypeptidase dimer shows that the two subunits in the HPP dimer differ by 15° in mutual orientation. Also, the helical subdomain forming part of the cap domains is very different. In addition, the HPP precursor cap domain contains a 'maturation' subdomain of 49 residues which fills the active-site cleft. Merely removing the 'excision' peptide located in the maturation subdomain does not render the catalytic triad solvent accessible. Conclusion The activation mechanism of HPP is unique among proteases with known structure. It differs from the serine proteases in that the active site is preformed in the zymogen, but is blocked by a maturation subdomain. In contrast to the zinc metalloproteases and aspartic proteases, the chain segment physically rendering the catalytic triad solvent inaccessible in HPP is not cleaved off to form the active enzyme. The activation must be a multi-step process involving removal of the excision peptide and major conformational changes of the maturation subdomain, whereas the conformation of the enzymatic machinery is probably almost, or completely, unaffected.
KW - human protective protein
KW - lysosomal storage disease
KW - protease precursor activation
KW - serine carboxypeptidase
UR - http://www.scopus.com/inward/record.url?scp=0029645906&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0029645906&partnerID=8YFLogxK
U2 - 10.1016/S0969-2126(01)00260-X
DO - 10.1016/S0969-2126(01)00260-X
M3 - Article
C2 - 8591035
AN - SCOPUS:0029645906
SN - 0969-2126
VL - 3
SP - 1249
EP - 1259
JO - Structure
JF - Structure
IS - 11
ER -